Trial intelligence / Profile preview

Comparison of LAAM, Buprenorphine, and Methadone for Opioid Dependence

NCT00344812Phase 2Completed

Sponsor
Johns Hopkins University
Start
Jan 1996
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of levacetylmethadol, buprenorphine in opioid use disorder (OUD), sponsored by Johns Hopkins University. Started Jan 1996; status: completed.

02

Drugs

levacetylmethadolbuprenorphine
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on NCT00344812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00344812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call